CBSET, a preclinical research company, announced that it has appointed Michael Naimark as director of business development.
Most recently, Mr. Naimark was employed by the Neural Stem Cell Institute (NSCI) as project manager overseeing the development of a cell-based therapy for macular degeneration under a 4-year award from the New York Stem Cell Foundation.

Previously, Mr. Naimark was co-owner of Care Research, a preclinical research organization where he provided operational, sales, and marketing oversight as Director of Surgical Models.

Prior to founding Care Research, Mr. Naimark helped launch Preclinical Research Services Inc., a preclinical research organization, and served as senior study director for several years. ■

• PTC appoints Corinna Lathan to board
• J.Jill appoints James S. Scully to board
• Raytheon elects Robert O. Work as director
• Xenetic Biosciences appoints three directors
• Insulet appoints two to board

---

More inside POST